Amicus Therapeutics, Inc.
FOLD
$6.83
$0.131.94%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | 319.04% | 57.13% | 67.58% | -43.07% | -56.85% |
| Total Depreciation and Amortization | -5.94% | -0.55% | 1.30% | -1.28% | -2.06% |
| Total Amortization of Deferred Charges | 4.01% | 2.50% | 5.46% | -0.93% | -25.66% |
| Total Other Non-Cash Items | -10.19% | 1.78% | -35.99% | 13.19% | 160.21% |
| Change in Net Operating Assets | 0.54% | -496.48% | 149.70% | -3,306.61% | 102.13% |
| Cash from Operations | 82.95% | -201.23% | 176.41% | -958.73% | 109.02% |
| Capital Expenditure | 19.10% | 67.58% | 39.37% | -4.62% | -10.61% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -158.06% | 265.85% | -323.35% | 142.06% | -159.54% |
| Cash from Investing | -159.50% | 255.94% | -391.59% | 131.46% | -166.98% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -279.17% | 166.67% | 14.29% | 99.99% | -1,316,790.32% |
| Issuance of Common Stock | -90.61% | 2,328.51% | -75.01% | -89.29% | -19.39% |
| Repurchase of Common Stock | 70.34% | -65.80% | 89.93% | -968.43% | 33.32% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -93.97% | 2,222.52% | 93.56% | -262.11% | -78.18% |
| Foreign Exchange rate Adjustments | 161.79% | -1,610.20% | 83.81% | 53.51% | -123.11% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -182.18% | 5,697.94% | 98.83% | -130.21% | -131.18% |